department of internal audit clinical and laboratory test ... review... · 15 no letter sent...
TRANSCRIPT
Department of Internal Audit
Clinical and Laboratory
Test Result Notifications Audit
Audit Review Committee Update
August 2, 2017
1
Internal Audit is evaluating the design and effectiveness of the patient notification process for clinical laboratory and radiologic test results.
In addition, we are reviewing and evaluating all relevant clinical data from April 1, 2014 through March 31, 2017.
2
Test areas:◦ Cervical Cancer/HPV (Pap Smear)◦ Colorectal Cancer◦ HIV and STDs◦ Hepatitis B and C ◦ Breast Cancer (Mammography)◦ Tuberculosis
Test locations:◦ NW and SE Health Department clinics and testing
services provided by Community-Based Testing
3
Our audit excludes:
◦ Clinic testing services for which patients receive results in-clinic at the time of their visit◦ Evaluation of the quality of provider diagnoses◦ Patient follow-through on referrals for services◦ Subsequent treatment provided by the County to
patients◦ Aging report requested by the Audit Review
Committee and other activities stated in external consultants’ scope of work
4
5
Key Milestones StatusAudit planning Completed
Conduct risk assessment Completed
Define and validate departmental process objectives Completed
Interview departmental process owners Completed
Map workflows and identify key internal controls and control gaps
Completed
Identify and confirm availability of relevant data for testing purposes
Completed
Obtain internal electronic medical record (EMR) data for testing purposes
Completed
Obtain external electronic health record data for testing purposes
Completed
6
Key Milestones StatusCommunicate preliminary issues based on process design to Health Department Executive Leadership
Completed
Communicate/compare issues and Pap smear results with consultants
Completed
Identify instances of non-compliance to applicable criteria
In process
Develop recommendations for improvement based on results of testing
In process
Communicate final issues to Health Department Executive Leadership
Pending
Preliminary Results and Recommendations Herein Subject to Final Management Review and Indexing and Referencing Process
7
Testing Methodology◦ Reviewed patient electronic medical records (EMR) to
determine whether the County completed the required number of attempts to notify patients of abnormal or unsatisfactory test results
◦ Based notification criteria on available policy and management corroboration
◦ Identified in the EMR whether the patient was successfully notified
◦ Identified patient records that did not meet notification requirements
◦ Did not evaluate patient follow-through on referrals for services
8
Pap Smear Testing Summary Counts
Testing Timeframe Total OrdersTotal
Abnormal Results
April 2014 – January 2015
2,150482
(manual review)
February 2015 – March 2017
5,750925
(data extraction)
TOTAL 7,900 1,407
9
10
Repeat Pap3-6 months176 (13%)
Follow-upin 1 Year
255 (18%)
Follow-up in3-5 years380 (27%)
Colposcopy596 (42%)
Abnormal/Unsatisfactory Pap Results by Provider Instructions
Pap Smear Exceptions Summary
Refer for Colposcopy
Requirements Number of Exceptions* Percentage of Exceptions
1st Letter Sent 48 of 596 8%
2nd Letter Sent 141 of 427 33%
3rd Letter Sent
-Certified Letter
109 of 201
43 of 92
54%
47%
11
*Population number reflects patients we could not confirm were successfully notified of test results.
Pap Smear Exceptions Summary
Repeat Pap in 3-4 or 6 months
Requirements Number of Exceptions* Percentage of Exceptions
1st Letter Sent 18 of 176 10%
2nd Letter Sent 51 of 123 41%
3rd Letter Sent
-Certified Letter
32 of 54
17 of 22
59%
77%
12
*Population number reflects patients we could not confirm were successfully notified of test results.
Pap Smear Exceptions Summary
Follow-up in 1 year
Requirements Number of Exceptions* Percentage of Exceptions
1st Letter Sent 7 of 255 3%
2nd Letter Sent 192 of 213 90%
3rd Letter Sent
-Certified Letter
13 of 16
1 of 3
81%
33%
13
*Population number reflects patients we could not confirm were successfully notified of test results.
Pap Smear Exceptions Summary
Follow-up in 3-5 years
Requirements Number of Exceptions* Percentage of Exceptions
1st Letter Sent 50 of 380 13%
2nd Letter Sent 290 of 298 97%
3rd Letter Sent
-Certified Letter
6 of 7
1 of 1
86%
100%
14
*Population number reflects patients we could not confirm were successfully notified of test results.
15
No Letter Sent ExceptionsReferred for Colposcopy, Repeat Pap in 3-6 Months, Follow-up in 1 Year
0 0 2 2 2 1 19 5
2030
10
20
40
60
80
100
120
Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar
2014 2014 2014 2015 2015 2015 2015 2016 2016 2016 2016 2017
Referred for Colposcopy Repeat Pap in 3-6 months Follow-up in 1 Year All Exceptions
Nu
mb
er
Ab
no
rmal
Pap
s Te
ste
d
16
No Letter Sent ExceptionsReferred for Colposcopy
0 0 1 1 0 0 1 1 3
13
27
10
10
20
30
40
50
60
70
80
Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar
2014 2014 2014 2015 2015 2015 2015 2016 2016 2016 2016 2017
Nu
mb
er
Ab
no
rmal
Pap
s Te
ste
d
Exceptions
17
No Letter Sent ExceptionsRepeat Pap in 3-6 Months
0 0 1 1 20 0
8
2 31 00
5
10
15
20
25
30
Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar
2014 2014 2014 2015 2015 2015 2015 2016 2016 2016 2016 2017
Nu
mb
er
Ab
no
rmal
Pap
s Te
ste
d
Exceptions
18
No Letter Sent ExceptionsFollow-up in 1 Year
0 0 0 0 0 1 0 0 0
42
00
5
10
15
20
25
30
35
40
Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar
2014 2014 2014 2015 2015 2015 2015 2016 2016 2016 2016 2017
Nu
mb
er
Ab
no
rmal
Pap
s Te
ste
d
Exceptions
19
No Letter Sent ExceptionsFollow-up in 3-5 Years
1 2 3 4 7 6 610
5 40 20
10
20
30
40
50
60
70
80
Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Oct-Dec Jan-Mar
2014 2014 2014 2015 2015 2015 2015 2016 2016 2016 2016 2017
Nu
mb
er
Ab
no
rmal
Pap
s Te
ste
d
Exceptions
Audit Team
Felicia Stokes, Audit Manager
◦ CIA, CISA, CRMA
Chinyere Brown, Auditor-in-Charge
◦ CIA, CFE
Deborah Caldwell, Information Technology Auditor
◦ CIA, CISA
Joanne Prakapas, Director
◦ CPA/CFF, CIA, CRMA, CFE
20
QUESTIONS
21